Login

NESTLE SA SEC Filings

Filed On Filing
20 Feb 2026 F-6 POS
02 Oct 2024 SC 13D/A
02 Oct 2024 Form 3: Nestle Sa, 10% owner and 1 other · Seres Therapeutics, Inc.

Holds 21,879,753 shares of Common Stock, par value $0.001

17 Oct 2022 Form 4: Societe des Produits Nestle S.a., 10% owner and 1 other · Axcella Health Inc.

Bought 3,658,536 shares ($6M)

16 Mar 2022 Form 4: Societe des Produits Nestle S.a., 10% owner and 1 other · Axcella Health Inc.

Bought 3,141,361 shares ($6M)

12 Mar 2021 Form 3: Nestle Sa, 10% owner and 1 other · Prometheus Biosciences, Inc.
09 Sep 2020 Form 4: Societe des Produits Nestle S.a., 10% owner and 1 other · Axcella Health Inc.

Acquired 4,305,541 shares (Other Transaction) ($19M)

21 May 2020 Form 4: Nestle Health Science Us Holdings, Inc., 10% owner and 4 others · Axcella Health Inc.

Bought 1,936,842 shares ($9.2M)

24 Apr 2020 Form 4: Societe des Produits Nestle S.a., 10% owner and 1 other · Aimmune Therapeutics, Inc.

Bought 1,000,000 shares ($32M) · Bought 525,634 shares ($168M) · Acquired 12,727,113 shares (Other Transaction) ($205M) · 1 more

24 Apr 2020 Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 4 others · Aimmune Therapeutics, Inc.

Holds 11,727,113 shares of Common Stock

24 Apr 2020 Form 4: Nestle Health Science Us Holdings, Inc., 10% owner and 2 others · Aimmune Therapeutics, Inc.

Bought 937,500 shares ($30M) · Bought 3,237,529 shares ($98M)

14 Feb 2020 Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 4 others · Axcella Health Inc.

Holds 2,368,699 shares of Common Stock

23 Nov 2016 Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 2 others · Aimmune Therapeutics, Inc.

Holds 7,552,084 shares of Common Stock

01 Jul 2015 Form 4: Nestle Health Science Us Holdings, Inc., 10% owner and 2 others · Seres Therapeutics, Inc.

Received 1,333,333 shares as a grant or award ($24M)

29 Jun 2015 Form 4: Nestle Health Science Us Holdings, Inc., 10% owner and 2 others · Seres Therapeutics, Inc.

Received 3,611,111 shares by conversion

25 Jun 2015 Form 3: Nestle Health Science Us Holdings, Inc., 10% owner and 2 others · Seres Therapeutics, Inc.

Holds 1,944,444 shares of Common Stock

07 Jul 2009 F-6EF
03 Jul 2008 424B3
01 May 2008 F-6EF
07 May 2007 FORM F-6 POS

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support